PDGFRA and glioblastoma: NG2 and PDGFRα are key factors for cellular proliferation and motility. PDGF expression supports tumoral development of GBM, while amplification of PDGFRα significantly promotes tumoral aggressive behavior and is correlated to ATRX loss.